The report "Fill Finish Manufacturing Market by Consumables (PFS [System, Plunger Stoppers, Glass, Polymer], Vials [Bulk, RTU], Vial Stoppers, Cartridges, Cell Therapy Bags), Instruments (Integrated), Type (Automated), Services, Competition - Global Forecast to 2031", is projected to grow from USD 19.75 billion in 2026 and to reach USD 30.37 billion by 2031, at a Compound Annual Growth Rate (CAGR) of 9.0% during the forecast period.
Browse 700 market data tables and 60 figures spread through 550 pages and in-depth TOC on "Fill Finish Manufacturing Market by Consumables (PFS [System, Plunger Stoppers, Glass, Polymer], Vials [Bulk, RTU], Vial Stoppers, Cartridges, Cell Therapy Bags), Instruments (Integrated), Type (Automated), Services, Competition - Global Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/fill-finish-manufacturing-market-6249609.html
The global fill finish manufacturing market is experiencing growth, driven by the GLP-1/ Incretin Injectables for obesity driving demand outpacing capacity and rising biosimilars & ADC pipeline expansion driving sterile injectable contract manufacturing growth.
The consumables segment accounted for the largest share of the global fill finish manufacturing market, by product, in 2025.
Based on product, the fill finish manufacturing market is segmented into consumables and instruments. The consumables segment accounted for the largest share of the fill-finish manufacturing market in 2025, driven by increasing demand for sterile injectable drugs, biologics, and biosimilars. Products such as vials, syringes, cartridges, stoppers, and other components are essential for maintaining sterility, ensuring product integrity, and supporting injectable fill finish operations. Growing adoption of ready-to-use components and stringent regulatory requirements continue to drive recurring demand, reinforcing the segment’s dominant position in the market.
Contract manufacturing organization is estimated to be the fastest-growing end user segment in the fill finish manufacturing market.
Contract manufacturing organizations are expected to be the fastest-growing end user segment in the fill-finish manufacturing market during the forecast period. Growth is driven by increasing outsourcing of fill finish operations by pharmaceutical and biotechnology companies seeking to reduce costs, access specialized expertise, and accelerate time-to-market. Expanding biologics, biosimilars, and advanced therapy pipelines, combined with ongoing investments in aseptic filling technologies and production capacity, continue to strengthen demand for outsourced fill-finish services.
Europe accounted for the largest share of the global fill finish manufacturing market in 2025.
The fill finish manufacturing market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. In 2025, Europe accounted for the largest share of the global market, driven by its strong pharmaceutical and biopharmaceutical manufacturing base, extensive CDMO network, and widespread adoption of advanced aseptic processing technologies. The region benefits from stringent regulatory standards, significant investments in biologics and vaccine manufacturing, and the presence of leading fill-finish equipment providers, packaging suppliers, and sterile drug manufacturers. Ongoing capacity expansions and increasing demand for biologics, biosimilars, and injectable therapies continue to support market growth across Europe.
Key players in the fill finish manufacturing market include West Pharmaceutical Services, Inc. (US), BD & Co. (US), Syntegon Technology GmbH (Germany), I.M.A. S.P.A. (Italy), Gerresheimer AG (Germany), AptarGroup, Inc. (US), Dätwyler Holding Inc. (Belgium), Danaher Corporation (US), Stevanato Group S.p.A. (Italy), OPTIMA (Germany), Bausch+Ströbel (Germany), Groninger & Co. Gmbh (Germany), SGD PHARMA (France), SCHOTT (Germany), Nipro Corporation (Japan), Bausch Advanced Technology Group (US), and Maquinaria Industrial Dara, SL (Spain).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: [email protected]
Visit Our Website: https://www.marketsandmarkets.com